MDWD 17.58 MediWound Ltd.

⇒

Stock List ⇒ MediWound Ltd.

Range:	7.45-24.0	Vol Avg:	60787	Last Div:	0	Changes:	-0.53
Beta:	0.83	Cap:	0.19B	Currency:	USD	Exchange:	NASDAQ
Sector:	Healthcare			IPO:	Thu Mar 20 2014	Empoloyees:	100
CUSIP:	M68830104	CIK:	0001593984	ISIN:	IL0011316309	Country:	IL
CEO:	Mr. Ofer Gonen B.Sc.			Website:	https://www.mediwound.com

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Stock Details

MDWD 28

H.C. Wainwright Reiterates Buy Rating on MediWound Ltd (MDWD)

Swayampakula Ramakanth·Fri Oct 11 2024

H.C. Wainwright

MDWD 36

Oppenheimer Reiterates Outperform Rating on MediWound Ltd (MDWD)

Francois Brisebois·Wed May 29 2024

Oppenheimer

MDWD 17.58 MediWound Ltd.

Stock Details

MDWD 28

MDWD 36

Про сайт

Новини маркету

Ринки

Найкращі для покупки